Characterization of novel mouse esophageal squamous cell carcinoma cell lines and their utility as preclinical models

Esophageal squamous cell carcinoma (ESCC) has a high incidence, poor treatment response, and high mortality. Subcutaneous transplant tumor models are commonly used to study the immunosuppressive tumor microenvironment and its impact on immunotherapy . In this study, we established two new ESCC mouse cell lines, mEC525M and mEC586F, from 4NQO-induced ESCC mouse models of different sexes. We compared their proliferation, motility, and molecular characteristics with existing lines (HNM007, AKR, mEC25) using in vitro experiments and whole-exome sequencing. Treatment sensitivity analysis of all murine ESCC tumor cell lines revealed that AKR and HNM007 cells were more responsive to chemotherapy, mEC25 cells were more sensitive to radiotherapy, whereas mEC525M and mEC586F cells exhibited greater sensitivity to immunotherapy . Multiplex immunohistochemistry (mIHC) staining analysis revealed differences in immune infiltration among the tumors derived from the five mouse ESCC cell lines , with the highest proportion of T cells in mEC525M tumors, the highest proportion of CD11b + myeloid cells in mEC586F tumors and the highest proportion of CD19 + B cells in mEC25 tumors. In addition, RNA sequencing results also revealed differences in immune responses exhibited by tumor tissues derived from the five mouse ESCC cell lines after anti-PD1 treatment. Therefore, this study offers a valuable tool for investigating the immune microenvironment in ESCC and supports the selection of mouse models for preclinical ESCC research. • Established two novel sex-specific ESCC mouse cell lines, mEC525M and mEC586F. • Genotypic similarities exist between murine and human ESCC cells. • Difference in chemotherapy, radiotherapy and immunotherapy sensitivity of the five types of mouse-derived esophageal cancer cells. • MEC525M and mEC586F cell lines show distinct immune infiltration after anti-PD1 therapy.